Application of 25-National Eye Institute Visual Function Questionnaire in ophthalmological patients
Author(s) -
Luciano Mesquite Simmo,
Carissa Fouad Ibrahim,
Senice Alvarenga Rodrigues Silva,
Thai Nunes Andrade,
Doora Faleiros Leite,
Roberto Ferreira de Almeida Arajo
Publication year - 2020
Publication title -
isp medicine
Language(s) - English
Resource type - Journals
ISSN - 2693-0226
DOI - 10.52274/ispmed20201025
Subject(s) - medicine , ophthalmology , diabetic retinopathy , macular degeneration , glaucoma , quality of life (healthcare) , optic neuritis , optic neuropathy , diabetes mellitus , optometry , optic nerve , nursing , psychiatry , multiple sclerosis , endocrinology
Objective: To compare the vision-targeted health related quality of life (HRQOL) between neuro-ophthalmological patients and other eye diseases by the National Eye Institute 25-Item Visual Function Questionnaire. Methods: Cross sectional study with a control group and patients with the following pathologies: primary open-angle glaucoma (POAG), diabetic retinopathy (DR), age-related macular degeneration (ARMD), non-arteritic ischemic optic neuropathy (NAION), intracranial hypertension (IH), optic neuritis (ON), ptosis and cataract. Results: All comparisons of the subscales scores among the control group and the patient groups were statistically significant (p<0.05) except for “ocular pain” (p=0.160), “social functioning” (p=0.052) and “peripheral vision” (p=0.112). The control group had the best scores across all dimensions of the NEI VFQ-25. Interestingly, the ARMD and cataract groups presented the best and worst total scores of NEI VFQ-25, respectively. The lowest subscales scores were found in the cataract, in the NAION/ON, and in the POAG groups. Finally, the comparison between the NAION/ON/IH patients and the other eye diseases did not show statistical significance in any subscale. Conclusion: The NEI VFQ-25 showed the impact of various eye conditions in vision-targeted HRQOL, and no difference was measured between neuro-ophthalmological patients and other eye diseases
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom